Recommend Cancer Biology & Therapy to your librarian for 2008. Download the form here.

Sign up for Table of Contents Alerts.

Email this page Print this page

Commentary

HDAC Inhibitors: Double Edge Sword for TRAIL Cancer Therapy?

Simone Fulda

volume 4 | issue 10

October 2005
Pages: 1113-1115

We now provide open access to journal articles published online for one year or more. This article may be downloaded at the following link:

 Download PDF

If the document does not open, please right-click on the link (control-click on a Macintosh) and select the option to save the file to disk.

Commentary to:

Histone Deacetylase Inhibitors Modulate Renal Cell Carcinoma Sensitivity to TRAIL/Apo-2L-Induced Apoptosis by Enhancing TRAIL-R2 Expression
Rebecca L. VanOosten, Jill M. Moore, Bahri Karacay and Thomas S. Griffith

---

We now provide open access to journal articles published online for one year or more. This article may be downloaded at the following link:

 Download PDF

If the document does not open, please right-click on the link (control-click on a Macintosh) and select the option to save the file to disk.